Trial Condition(s):

Atrial Fibrillation

Treatment Pattern of NOACs (non-vitamin K oral anticoagulants) in Outpatient Users in Colombian Databases (TREND)

Bayer Identifier:

20104

ClinicalTrials.gov Identifier:

NCT03474757

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This population-based descriptive study will characterize first-time users of three NOACs (rivaroxaban, dabigatran and apixaban) in prevention of stroke in non-valvular atrial fibrillation (SPAF) patients and will assess the patterns of drug utilization in routine general practice in Colombia

Inclusion Criteria
- First prescription of NOACs (rivaroxaban, dabigatran and apixaban) in the outpatient setting.
- Non valvular Atrial Fibrillation (NVAF) Patients 
- aged ≥18 years 
- at least one year of enrollment in the Audifarma database 
- one year since first encounter with healthcare provider will be included in the study
Exclusion Criteria
- Patients with any record of index drug prescription prior to the enrolment period. 
- Patients who qualify as members of more than one cohort study on the same day

Trial Summary

Enrollment Goal
10528
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Xarelto (Rivaroxaban, BAY59-7939)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Many Locations

Many Locations, Colombia

Status
Completed
 

Trial Design